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ABSTRACT 
Background: Physician’s prescribing preference is increasingly used as an 
instrumental variable in studies of therapeutic effects. However, differences in 
prescribing patterns among physicians may reflect differences in preferences or 
in case-mix. Furthermore, there is debate regarding the possible assumptions for 
point estimation using physician’s preference as an instrument. 
Methods: A survey was sent to general practitioners (GPs) in The Netherlands, 
the United Kingdom, New Zealand, Ireland, Switzerland and Germany, asking 
whether they would prescribe levothyroxine to eight fictitious patients with 
subclinical hypothyroidism. We investigated (1) whether variation in 
physician’s preference was observable and to what extent it was explained by 
characteristics of GPs and their patient populations and (2) whether the data 
were compatible with deterministic and stochastic monotonicity assumptions. 
Results: Levothyroxine prescriptions varied substantially amongst the 526 
responding GPs. Between-GP variance in levothyroxine prescriptions (logit 
scale) was 9.9 (95% CI 8.0;12) in the initial mixed-effects logistic model, 8.3 
(6.7;10) after adding a fixed effect for country and 8.2 (6.6;10)after adding GP 
characteristics. The occurring prescription patterns falsified the deterministic 
monotonicity assumption. All cases in all countries were more likely to receive 
levothyroxine if a different case of the same GP received levothyroxine, which 
is compatible with the stochastic monotonicity assumption. The data were 
incompatible with this assumption for a different definition of the instrument. 
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Conclusions: Our study supports the existence of physician’s preference as a 
determinant in treatment decisions. Deterministic monotonicity will generally 
not be plausible for physician’s preference as an instrument. Depending on the 
definition of the instrument, stochastic monotonicity may be plausible. 
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INTRODUCTION 
Instrumental variable (IV) analysis is increasingly used in observational studies 
of therapeutic effects, with the aim of circumventing confounding by indication. 
This method requires a variable (the instrument) that meets the following 
conditions: (1) is associated with treatment, (2) does not affect the outcome 
other than through treatment (exclusion restriction) and (3) does not share a 
common cause with the outcome (independence assumption).1;2 One such 
instrument is physician’s prescribing preference, which exploits the notion that 
prescribing by a medical doctor is influenced not only by prognostic 
characteristics of the patient, but also by a general preference of the doctor for 
some type of therapy when different treatment options are available. 
 
Because underlying preference cannot be observed, physician’s preference-
based IV studies use an estimate of physician’s preference based on prescribing 
behaviour. The question remains, however, whether differences in prescribing 
behaviour between physicians truly reflect differences in preference rather than 
just differences in their patient populations. Furthermore, the three main IV 
conditions described above are only sufficient for the estimation of bounds of a 
treatment effect.3 To obtain a point estimate an additional (fourth) assumption is 
required. The assumption of no heterogeneity of treatment effects, under which 
the average treatment effect in the population can be estimated, is often 
implausible.3 A frequently used alternative is the monotonicity assumption, first 
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described by Imbens and Angrist.4  According to the original (deterministic) 
monotonicity assumption, the instrument may only be related to treatment 
monotonically in one direction for all subjects.2;4-7 A less strict, stochastic 
version of the monotonicity assumption has been proposed, as we will explain 
later.5-7  
 
The notion that physician’s underlying prescribing preference affects 
prescribing behaviour cannot be proven in IV study data (at the most, the 
assumption that physician’s estimated prescribing preference is unrelated to 
characteristics of the physician’s patient population can be explored to some 
extent). Furthermore, the deterministic monotonicity assumption is generally 
not verifiable within IV study data and the validity of the stochastic 
monotonicity assumption can only be explored to some extent. Swanson et al. 
recently proposed using a study design in the form of a survey, asking 
physicians what their treatment decision would be for the same set of cases, to 
assess the monotonicity assumption empirically.2 Here we perform such a study, 
using data from a survey originally performed with the aim of establishing 
differences in treatment strategies of general practitioners (GPs) for subclinical 
hypothyroidism by country and by patient characteristics.8 These data were 
therefore not primarily intended for our current study, but can nevertheless 
provide a valuable insight into the plausibility of the different monotonicity 
assumptions. Our aims are twofold, (1) to establish whether variation in 
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physician’s preference regarding treatment of subclinical hypothyroidism is 
observable when GPs are presented with the same set of patients and to what 
extent this variation is explained by characteristics of the GPs and (2) to 
establish to what extent the data are compatible with the deterministic and 
stochastic monotonicity assumptions. 
 
METHODS 
Study data 
The survey procedures have been described in detail elsewhere.8 An online 
survey was e-mailed to 2710 GPs in The Netherlands, Germany, England, 
Ireland, Switzerland and New Zealand. It contained eight fictitious cases of 
women with subclinical hypothyroidism. All cases had a normal BMI, non-
specific complaints resulting in fatigue and a normal free thyroxine level. Cases 
varied in age (70 years/ 85 years), vitality status (vita /vulnerable) and thyroid 
stimulating hormone (TSH) (6 mU/L/15 mU/L), (Table 1). For each case, GPs 
were asked if they would start treatment, and, if so, what levothyroxine starting 
dose they would choose. For the purposes of this study, we only consider the 
responses on whether treatment would be started. Furthermore, GPs were asked 
questions about their gender, years of experience as a GP, the percentage of 
elderly patients registered in their practice, the time since the last diagnosis of 
subclinical hypothyroidism and the time since last starting levothyroxine 
treatment in a patient with subclinical hypothyroidism. For the full survey, we 
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refer to Appendix 2 of Den Elzen et al. , which reports the study for which the 
survey was originally performed.8 The survey study was exempt from ethical 
review in in the Netherlands, Germany, England, Switzerland, and New 
Zealand, as it discussed only fictional patients. In Ireland, the Clinical Research 
Ethics Committee of the Cork Teaching Hospital approved the survey.8 
 
Possible assumptions for point estimation 
Deterministic monotonicity 
For a dichotomous instrument the deterministic monotonicity assumption is 
usually defined as the absence of ‘defiers’.1;2;6;9  The IV analysis then estimates 
a local average treatment effect among the ‘compliers’.1;4  These ‘compliers’ or 
‘marginal patients’ are those patients who would receive treatment at the 
‘encouraging’ value of the instrument (e.g. preference for treatment), but not at 
the ‘non-encouraging’ value of the instrument (e.g. preference for no 
treatment).1;5;9;10 As discussed by Swanson et al. and Small et al, for physician’s 
preference as an IV, the compliance class (whether the patient is a complier, 
defier, always taker or never taker) is generally not well defined.2;6 
 
Hernán and Robins have formulated the deterministic monotonicity assumption 
for physician’s preference as a continuous instrument.3 This would translate to 
the example of subclinical hypothyroidism as follows: if physician A would 
treat a certain patient with subclinical hypothyroidism with levothyroxine, then 
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all physicians with a preference greater than or equal to the preference of 
physician A should treat that patient with levothyroxine. It is this assumption 
which we will assess for our survey data. It would correspond to global 
monotonicity as described by Swanson et al. 2 (Local monotonicity was also 
described by Swanson et al: for this somewhat more relaxed version of the 
assumption monotonicity must hold for specific pairs of physicians.2) For 
continuous instruments, the local average treatment effect is a weighted average 
of treatment effects in multiple subgroups of patients (e.g. subgroups of patients 
who would receive levothyroxine from physicians with a certain preference but 
not from physicians with a lower preference).1;3  
 
 
 
 
Stochastic monotonicity 
The alternative to deterministic monotonicity proposed is the stochastic 
monotonicity assumption, which states that the instrument should be related to 
treatment monotonically across subjects within strata of a sufficient set of 
measured and unmeasured common causes of treatment and the outcome.6 
 
If we view the cases in our survey not as individual cases but as strata of 
patients with the same relevant characteristics, the stochastic monotonicity 
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assumption requires GPs’ preference to be related to treatment monotonically in 
one direction across patients in each of these strata. This means that the 
probability of levothyroxine treatment for patients treated by GPs with 
preference A should be at least as high as for patients treated by GPs with a 
lower preference, within all strata of patients.  
 
Under the stochastic monotonicity assumption, the effect estimated is a 
weighted average of treatment effects in the different strata of patients, with 
more weight given to those strata in which the instrument is strongest.5;7 Small 
et al. have named this the strength-of-IV weighted average treatment effect 
(SIVWATE).6 We point out that, in their identification framework for the 
SIVWATE and local average treatment effect, Small et al. formulate the three 
main IV assumptions differently to how we formulated these assumptions in our 
introduction.6 
 
Analysis 
Variation in preference for levothyroxine and its determinants 
For each GP who completed all survey questions, we calculated the total 
number of cases treated with levothyroxine, as a measure of the GP’s relative 
preference for treatment with levothyroxine in subclinical hypothyroidism. 
To investigate the effect of GP characteristics on their tendency to prescribe 
levothyroxine, we used mixed-effects logistic regression. All cases completed 
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by the GPs were included, with treatment with levothyroxine (no/yes) as the 
outcome. We ran the following (pre-specified) models: 
Model 1: A random effect for GP and fixed effects for characteristics of the case 
(age 70 or 85, TSH 6 or 15 mU/L, vital or vulnerable disposition). 
Model 2: Model 1 plus a fixed effect for country. 
Model 3: Model 2 plus a fixed effect for GP gender and years of experience (<5, 
5-10, 11-15, 16-20, 21-25, >25 years). 
Model 4: Model 3 plus a fixed effect for percentage of patients in the GP’s 
practice aged ≥65 years (<10%, 10-20%, 20-30%, >30%) and time since last 
diagnosis of subclinical hypothyroidism (<1 wk, 1 wk-1 mth, 1 mth-1 yr, 1-3 
yrs, >3 yrs).  
The parameter of interest was the variance of the random effect of the GP 
(“between-GP variance in preference”), which is calculated on a log odds scale. 
The interest lies in whether this variance decreases as country and 
characteristics of the GP are added to the model. 
 
Deterministic monotonicity assumption 
To investigate the monotonicity assumption we made a matrix plot11 for each 
country, with cases 1 to 8 on the X-axis and the GPs, ordered from highest to 
lowest preference, on the Y-axis, the colour of each cell indicating whether 
levothyroxine was prescribed. This was used to visually examine whether the 
deterministic monotonicity assumption holds. GPs who did not complete the 
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survey were not included in these plots. eFigure 1 shows a matrix plot with the 
pattern expected if deterministic monotonicity holds completely: physicians 
with a certain preference always prescribe levothyroxine  to those cases for 
which physicians with the same or a lower preference prescribe levothyroxine. 
(From these plots, which show the complete data pattern, it is also possible to 
derive whether deterministic monotonicity could hold for specific instruments 
such as treatment of the previous patient of the same GP.)  
 
Stochastic monotonicity assumption 
The exact formulation of the stochastic monotonicity assumption depends on 
the definition of the instrument. Because Small et al.  discuss the stochastic 
monotonicity assumption in the context of a binary instrument, using treatment 
of the previous patient as an example, and because treatment of the previous 
patient is a frequently used physician’s preference-based instrument, we 
evaluated whether stochastic monotonicity could hold for this instrument. 
Because all GPs were presented with all cases in the same order, we cannot use 
the true previous case as instrument. We therefore considered each other case as 
a potential previous patient -- i.e. for each case there were seven potential 
previous patients per GP. We denote the potential previous patient as the ‘other 
patient’. Each possible index patient–other patient combination was classified 
according to the treatment of both patients and summed across GPs to a total per 
case (per country). For each case we calculated the probability of levothyroxine 
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treatment if the other patient received levothyroxine and if the other patient did 
not receive levothyroxine. 
 
As a sensitivity analysis, we also assessed the stochastic monotonicity 
assumption for the proportion of all other cases the same GP decided to treat 
(although we note that Small et al.  only discussed the stochastic monotonicity 
assumption with respect to a dichotomous instrument)6. We performed this 
analysis for the two countries with the largest number of responding GPs (The 
Netherlands and Switzerland). 
 
Missing data 
There was a technical problem in the electronic questionnaire sent to the Dutch 
GPs, resulting in 16 missing answers for case 6. Missing answers due to this 
technical problem were imputed, using logistic regression (10 imputations) with 
country, the answers for all other cases and characteristics of the GP as 
predictors. 
 
Analyses were performed using Stata 12 (College Station, TX: StataCorp LP. 
2011). 
 
RESULTS 
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A total of 526 GPs from eight countries responded to the survey. eTable 1 lists 
the response rates per country. The overall response rate was 19% (526/2710) 
and ranged from 4% (New Zealand) to 41% (The Netherlands). The number of 
responding GPs ranged from 21 from Ireland to 262 from Switzerland. Table 2 
shows the characteristics of the GPs. Of the 526 respondents, 468 (89%) 
answered all questions and 71% were male. The years of experience ranged 
from <5 years (8%) to >25 years (29%). Seventy percent of responding GPs had 
≥20% patients aged 65 years and over in their practice and the vast majority 
(91%) had diagnosed a patient with subclinical hypothyroidism within the last 
year. 
 
Variation in number of levothyroxine prescriptions 
Figure 1 displays the distribution per country of the total number of cases for 
which the GP decided to start levothyroxine. There was substantial variation in 
this total within each country. The most frequent number of levothyroxine 
prescriptions was 4 for the UK, New Zealand, Ireland and Switzerland, 0 for 
The Netherlands and 8 for Germany.  
 
Association between GP characteristics and treatment preference 
Table 3 displays results of the mixed-effects logistic regression used to 
investigate the effect of GP characteristics on levothyroxine prescription. 
Country explained some of the variance in levothyroxine prescription between 
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GPs, as shown by the reduction in between-GP variance from 9.9 (95% CI 
8.0;12) to 8.3 (6.7;10) after adding a fixed effect for country. Adding GP 
characteristics (Model 3) resulted in a very small reduction in between-GP 
variance in treatment to 8.2 (6.6;10). Adding time since last subclinical 
hypothyroidism diagnosis and the proportion of patients aged 65 years and over 
(Model 4) resulted in a similarly small reduction. There was therefore still 
substantial variation in levothyroxine prescription among GPs after adjusting 
for all available patient and doctor characteristics. 
 
Deterministic monotonicity assumption 
Figure 2 shows matrix plots per country of the treatment decisions for each case 
by each GP. GPs are ordered from highest (eight cases treated) to lowest 
preference (0 cases treated). The prescription patterns of the UK (Figure 2B) 
only showed a single violation of deterministic monotonicity: the GP who 
prescribed levothyroxine to five cases treated case 2 while the GP who 
prescribed levothyroxine to six cases did not treat case 2. There were more 
violations of deterministic monotonicity in the other countries. Treating all 
cases with a TSH of 15 mU/L was a common pattern in the UK, the 
Netherlands, New Zealand, Switzerland, and Ireland. For example, 75 of 89 
GPs who treated four cases in Switzerland decided to initiate levothyroxine in 
cases 3, 4, 7, and 8. In both the Netherlands and Switzerland, most GPs with a 
lower preference treated (one or more) cases with a high TSH only and most 
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GPs with a higher preference treated at least the high TSH cases. However, 
there was not a consistent pattern regarding the 5th, 6th,or 7th case treated, or the 
1st, 2nd,,or 3rd case treated within those with a TSH of 15 mU/L. Prescribing 
patterns in Germany differed from those in other countries: many GPs (25 of 
55) treated all cases with levothyroxine, and for the other GPs the prescribing 
patterns were less consistent. 
 
Stochastic monotonicity assumption 
Table 4 displays the probability of levothyroxine prescription per case, 
dependent on treatment of a different patient of the GP. The probability of 
levothyroxine prescription was higher if the other patient was prescribed 
levothyroxine for nearly all cases in all countries. Exceptions were case 1 in the 
UK and in New Zealand, for whom treatment probability did not differ 
depending on the other patient’s treatment. Importantly, there were no cases for 
whom the probability of levothyroxine was higher if the other patient did not 
receive levothyroxine, i.e. the instrument was related to treatment in the same 
direction for all cases in all countries. The instrument strength (the difference 
between the probability of the index patient receiving levothyroxine if the other 
patient received levothyroxine and the probability of the index patient receiving 
levothyroxine if the other patient did not receive levothyroxine) varied across 
cases within each country. For example, in the Netherlands, it varied from 20% 
(case 1) to 47% (case 4).  
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 The sensitivity analysis in which we evaluated the stochastic monotonicity 
assumption for a continuous instrument (the proportion of all other cases 
treated) showed violations of this assumption (eTable 2). Although for both 
countries the probability of treatment increased as the value of the instrument 
increased for all cases, it did not increase monotonically. Specifically, the 
probability of treatment was higher if 3/7 other cases were treated than if 4/7 
other cases were treated. 
 
DISCUSSION 
This survey study showed marked within-country variation amongst GPs in 
their tendency to treat patients with subclinical hypothyroidism with 
levothyroxine. Presenting the same cases to all GPs ensured that observed 
differences in prescribing behaviour truly reflect differences in preference, 
rather than differences in case-mix. The existence of underlying relative 
preference for levothyroxine treatment for subclinical hypothyroidism patients 
amongst GPs as a “pseudo-random” phenomenon is further supported by the 
very limited decrease in between-GP variance in levothyroxine prescription 
after adjusting for GP characteristics. Even country explained a relatively small 
amount of the variation: the within-country variation is considerable compared 
to between-country differences. 
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The minimal amount of between-GP variance in levothyroxine prescription 
explained by GP characteristics within countries is reassuring with regard to 
main IV assumptions. If GP gender and years of experience were related to 
relative preference for levothyroxine, this would threaten the validity of the 
exclusion restriction assumption: years of experience in particular may affect 
the prognosis of subclinical hypothyroidism patients through other ways than 
levothyroxine prescription. If the proportion of older patients were related to 
preference for levothyroxine this would threaten the validity of the 
independence assumption: the baseline prognosis of patients would then differ 
according to GP’s preference. With regard to the independence assumption, it is 
important to make the distinction between physician’s preference as assessed in 
this survey and physician’s preference as it is typically used as IV in 
observational studies. A measure of preference based on previous patients of the 
physician is typically used: the treatment of these previous patients is 
determined both by the underlying preference of the physician and by 
characteristics of these patients.2 Physicians with the same underlying 
preference (i.e. who would give the same responses to our survey questions) can 
have a different case-mix of patients, and an estimate of their preference based 
on treatment of these patients would then differ. Although the assumption of no 
confounding seems to hold for underlying preference in our survey data, it may 
well be violated in observational data if measures of preference based on 
treatment of previous patients are used, due to confounding by case-mix. This 
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issue of confounding of instruments based on prescribing history was also 
discussed by Swanson et al. 2 
 
The preference patterns observed within the six countries deviated in varying 
degrees from the pattern expected if the deterministic monotonicity assumption 
would hold. The violation of the deterministic monotonicity assumption in this 
survey with relatively simple case descriptions indicates it is unlikely to hold for 
physician’s preference as an instrument in true prescription data. For a 
dichotomous instrument, the bias in the local average treatment effect estimate 
caused by violation of deterministic monotonicity depends on the proportions of 
compliers and defiers and the difference in treatment effects for compliers and 
defiers.9 For a multi-levelled or continuous instrument, the bias caused by 
violation of the deterministic monotonicity assumption will be determined by 
analogous factors: i.e. the severity and pattern of the deviation from 
monotonicity, and the level of heterogeneity of treatment effects. In our 
example, heterogeneity is most likely to exist according to TSH levels, but 
looking at TSH only, there is relatively little violation of deterministic 
monotonicity.   
 
In these data, the stochastic monotonicity assumption was not falsified when 
treatment of a different patient of the same GP was used as an instrument. 
However, in the sensitivity analysis using the proportion of all other patients of 
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the same GP treated as an instrument, the data were not compatible with the 
stochastic monotonicity assumption for that instrument. This may be due to the 
specific setting of the study: a certain proportion of other patients treated often 
corresponds to a certain pattern of specific cases treated in these data. Overall, 
these results suggest that the stochastic monotonicity assumption may be 
plausible for physician’s preference-based IV studies, depending on how the 
instrument is defined. Estimates of preference based on a larger number of 
previous patients may be more likely in general to violate stochastic 
monotonicity, because the probability of treatment must increase monotonically 
across all levels of these instruments for all strata of patients.  
 
The effect estimate under the stochastic monotonicity assumption is not the 
local average treatment effect but the strength-of-IV-weighted treatment effect, 
a generalisation of the local average treatment effect with a similar 
interpretation.6 There has recently been discussion on the usefulness of the local 
average treatment effect. It centres around the question of whether the treatment 
effect for the compliers is a relevant effect,12;13 particularly because we cannot 
identify who the compliers are.12 The strength-of-IV-weighted treatment effect 
has similar drawbacks to the local average treatment effect: the interpretation is 
difficult, since it is a weighted average of effects in strata which we cannot 
identify and for which we do not know the weights.  
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The existing survey data used for this study provided a unique opportunity to 
investigate the assumptions underlying the use of physician’s preference as an 
IV, but also presented some limitations. One limitation is the low response rate, 
which may have affected our results in various ways. Responding GPs may be 
more aware of guidelines and more alike in their prescription patterns: i.e. the 
deterministic monotonicity assumption could be violated to a greater extent in 
the entire GP population. There may have been more ‘random’ variation in 
answers if all GPs had responded (i.e. if underlying preference is a stronger 
determinant of treatment in the respondents than in GPs overall). This would 
have reduced the overall strength of GP’s preference as an instrument. 
However, we would not expect it to affect the validity of the stochastic 
monotonicity assumption for treatment of one other case as the instrument: we 
do not expect such vastly different patterns among non-respondents that 
treatment of a particular case would be inversely related to treatment of a 
different case. 
 
All GPs were presented with the cases in the same order. Random ordering of 
the cases per GP would have been preferable for assessing preference in the 
context of an IV. It would have enabled us to use a true ‘previous case’ for the 
evaluation of the stochastic monotonicity assumption. Furthermore, the ordering 
of the cases may have had some influence on answers given for specific cases. 
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By evaluating the stochastic monotonicity assumptions across these eight 
patient types (strata) in the survey, we considered the characteristics that define 
these patient types, i.e. age, vitality status and TSH levels, to be a sufficient set 
of measured and unmeasured common causes of treatment and the outcome. 
While this may hold for the simplified survey data, this is unlikely to be a 
sufficient set in a true patient population. We were therefore only able to 
evaluate the stochastic monotonicity assumption for the simplified setting of the 
survey. Related to this, the fictitious cases in the survey were not intended to 
represent any particular population of subclinical hypothyroidism patients for 
whom we may want to estimate the effect of levothyroxine treatment. Rather, 
the survey was designed in such a manner that characteristics which were 
thought to be important in the treatment decision varied among the cases. The 
cases were intended to represent a well-known clinical decision problem: 
whether to treat subclinical hypothyroidism. In this sense estimating a treatment 
effect for this group would be of potential interest, although the types of 
subclinical hypothyroidism patients represented by the cases are limited. For 
example, the cases were all women and there was no variation in the symptoms 
with which they presented.  
 
Findings which may be of interest to clinicians are that we can distinguish 
several groups of factors which are related to the decision whether to treat a 
patient with subclinical hypothyroidism: characteristics of the patient, country 
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(and its guidelines), and GP’s preference. In this setting of treatment of 
subclinical hypothyroidism, the lack of stringent guidelines leaves substantial 
room for GP’s preference to play a role in treatment decisions. While this would 
provide an opportunity to utilize this variation in an IV study of the effect of 
treatment of subclinical hypothyroidism, the ultimate aim of such a study would 
paradoxically be to reduce this preference-based variation through the 
development of evidence-based guidelines. 
 
In conclusion, our study supports the existence of physician’s preference as a 
determinant in treatment decisions. Little of the variation in preference was 
explained by characteristics of the GP or their patient population, indicating that 
main IV assumptions may be plausible for physician’s treatment preferences. 
The deterministic monotonicity assumption did not hold and will generally not 
be plausible for physician’s preference as an instrument. The stochastic 
monotonicity assumption may be plausible, depending on how the instrument is 
defined. 
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Figure legends 
Figure 1. Distribution per participating country of the number of cases for 
which a GP would prescribe levothyroxine.  
A. The Netherlands (n=117)  B. United Kingdom (n=21)  C. New Zealand 
(n=25)   
D. Ireland (n=15)   E. Switzerland (n=235)  F. Germany (n=55) 
 
Figure 2. Matrix plots of the prescription patterns of the GPs within each 
country. GPs are ordered from highest to lowest preference, with their response 
for each case indicated by the colour of the cell (yes: dark-grey, no: light-grey, 
missing: mid-grey). GPs with equal preferences were ordered according to 
their preferences for case 1(first yes, then no) through to 8, and subsequently by 
their identification-number (if all answers were equal). 
A. The Netherlands (n=117)  B. United Kingdom (n=21)  C. New Zealand 
(n=25)  
D. Ireland (n=15)   E. Switzerland (n=235)  F. Germany (n=55) 
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Table 1. Age, vitality status and thyroid stimulating hormone (TSH) of the eight 
cases in the survey. 
 
 
 
 
 
 
 
 
 
Adapted from Den Elzen et al, British Journal of General Practice 2015. 
 
  
Case Age Vitality 
status 
TSH 
(mU/L) 
1 70 Vital 6 
2 70 Vulnerable 6 
3 70 Vital 15 
4 70 Vulnerable 15 
5 85 Vital 6 
6 85 Vulnerable 6 
7 85 Vital 15 
8 85 Vulnerable 15 
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Table 2. 
Characte
ristics of 
participa
ting 
general 
practitio
ners 
(GPs). 
GP characteristics No. (%) Total n=526 
Country  
The Netherlands 129 (25) 
United Kingdom 22 (4) 
New Zealand 31 (6) 
Ireland 21 (4) 
Switzerland 262 (50) 
Germany 61 (12) 
Male 373 (71) 
Experience as a GP (years)  
<5  41 (8) 
5-10  70 (13) 
11-15  90 (17) 
16-20  82 (16) 
21-25 88 (17) 
>25 155 (29) 
Patients aged 65 years and over in GP practice (%)  
<10 35 (7) 
10-20 122 (23) 
20-30 188 (36) 
>30 181 (34) 
Time since last subclinical hypothyroidism diagnosis  
<1 week 76 (14) 
1 week-1 month 194 (37) 
1 month-1 year 211 (40) 
Copyright © Wolters Kluwer Health, Inc. All rights reserved. Unauthorized reproduction of this article is prohibited.
AC
CE
PT
ED
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
1-3 years 27 (5) 
>3 years 18 (3) 
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Table 3 Between general practitioner (GP) variance in treatment 
Model Between GP variance (95% CI) 
1: Random effect for GP; fixed effect 
for age, TSH and vitality status of case 9.9 (8.0;12) 
2: Model 1 + fixed effect for country 8.3 (6.7;10) 
3: Model 2 + fixed effect for gender 
and years of experience  8.2 (6.6;10) 
4: Model 3 + fixed effect for time 
since last diagnosis of subclinical 
hypothyroidism and proportion of 
patients aged 65 years and over 
8.0 (6.5;9.9) 
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Table 4. Probability (%) of levothyroxine dependent on treatment of a 
different case by the same general practitioner (GP) 
 
Percentage of  yes answers per case within each country, dependent on the 
treatment of a different case (the ‘other patient’) by the same GP. Each other 
answer of the same GP was used as an ‘other patient’. Treatment of the 
‘previous patient’ is indicated by – (no levothyroxine) and + (levothyroxine). 
The columns indicate the following (in %): – : Pr[D=1|Z=0]; +: Pr[D=1|Z=1]; 
∆: Pr[D=1|Z=1]-Pr[D=1|Z=0]. 
 
 
Cas
e 
     Country  
Netherland
s 
(n=117) 
UK 
(n=21) 
New 
Zealand 
(n=25) 
Ireland 
(n=15) 
Switzerla
nd 
(n=235) 
Germany 
(n=55) 
–   + ∆ – + ∆ – + ∆ – + ∆ – + ∆ – + ∆ 
1 7 27 21 0 0 
0 4 4 0 27 47 
2
0 
1
7 
4
5 
2
8 
5
0 
8
9 
3
9 
2 4 27 23 4 6 
2 3 14 11 
1
1 45 
3
4 
1
0 
4
1 
3
1 
1
9 
7
3 
5
4 
3 44 90 46 
6
4 
10
0 
36 8
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10
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1
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8
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10
0 
1
6 
6
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3
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7
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9
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2
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0 
36 6
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2
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10
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1
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3
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5 
2
7 
5 4 27 22 2 8 
5 5 12 6 11 45 
3
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3
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2
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1
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4 
5
0 
6 6 26 20 2 8 
5 9 25 16 
2
2 50 
2
8 
1
1 
3
8 
2
7 
2
3 
7
2 
4
9 
7 39 85 46 
6
4 
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36 6
3 89 
2
6 
6
5 90 
2
5 
6
1 
9
0 
2
9 
6
5 
9
3 
2
8 
8 40 78 38 
5
9 94 
35 4
5 74 
2
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7
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1
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6
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 eFigure 1. Example of a matrix plot showing prescription patterns which would fulfil the monotonicity 
assumption. GPs are ordered from highest to lowest preference, with their response for each case 
indicated by the colour of the cell (yes: dark-grey, no: light-grey). 
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eTable 1. Response rates per country and overall 
 
 
 
 
 
 
 
 
 
Adapted from Den Elzen et al, British Journal of General Practice 2015. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Country Responses Surveys sent out Response rate (%) 
The Netherlands 129 315 41 
United Kingdom 22 178 34 
New Zealand 31 850 4 
Ireland 21 150 14 
Switzerland 262 1086 25 
Germany 61 178 34 
Total 526 2710 19 
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 eTable 2. Probability of levothyroxine dependent on treatment of all other cases by the same 
general practitioner (GP). 
 
Percentage of  yes answers per case within each country, dependent on the treatment of the other cases of the 
same GP. The column headings indicate the proportion of the other patients treated. 
 
 
 
Case 
Country 
The Netherlands (n=117)  Switzerland (n=235) 
0/7   1/7 2/7 3/7 4/7 5/7 6/7 7/7  0/7   1/7 2/7 3/7 4/7 5/7 6/7 7/7 
1 0 0 13 25 4 47 73 67  0 33 7 53 15 48 62 86 
2 0 0 0 12 1 42 81 100  0 14 12 22 6 37 73 94 
3 5 50 75 92 76 100 100 100  6 67 47 98 96 100 100 100 
4 0 44 86 100 86 100 84 98  0 45 39 98 88 88 100 100 
5 0 0 0 8 8 46 62 87  0 0 6 27 5 13 48 94 
6 0 0 0 21 10 28 46 80  3 17 12 36 6 26 53 89 
7 3 33 64 87 69 93 100 100  6 64 18 92 80 93 93 100 
8 5 50 70 87 58 75 79 80  3 58 36 95 74 88 100 100 
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